Published Erratum
doi: 10.1002/cti2.1429.
eCollection 2022.
Erratum: Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma
- PMID: 36349202
- PMCID: PMC9633864
- DOI: 10.1002/cti2.1429
Item in Clipboard
Published Erratum
Erratum: Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma
Clin Transl Immunology.
.
Abstract
[This corrects the article DOI: 10.1002/cti2.1268.].
© 2022 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of Australian and New Zealand Society for Immunology, Inc.
Erratum for
-
Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma.Clin Transl Immunology. 2021 Apr 29;10(4):e1268. doi: 10.1002/cti2.1268. eCollection 2021. Clin Transl Immunology. 2021. PMID: 33968404 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources